Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a site version update with no changes to study data or participant information.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed Revision: v3.4.1 and the lapse in government funding notice.
    Difference
    0.4%
    Check dated 2026-02-11T02:05:10.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a status update for the NIH Clinical Center; introduced revision tag v3.4.1 and removed v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T23:46:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a glossary option and updates the footer with QC-related metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:55:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Minor site version update from Revision: v3.3.3 to v3.3.4; this change does not affect the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:22:05.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a unified Locations section with site entries for California, District of Columbia, Maryland, and Pennsylvania. Removed the California Locations, District of Columbia Locations, Maryland Locations, Pennsylvania Locations subpages and the HHS Vulnerability Disclosure link.
    Difference
    0.5%
    Check dated 2025-12-23T09:59:03.000Z thumbnail image

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.